Literature DB >> 2712833

Cyclosporin A inhibits protein kinase C activity: a contributing mechanism in the development of nephrotoxicity?

R J Walker1, V A Lazzaro, G G Duggin, J S Horvath, D J Tiller.   

Abstract

Cyclosporin A modifies many intracellular functions in a variety of different cells. This study investigated the potential interaction between cyclosporin A and protein kinase C, as a possible mechanism for the development of nephrotoxicity. The activity of protein kinase C, in the cytosol of renal epithelial cells, was shown to be significantly inhibited in a dose-dependent manner by CSA. Activation of protein kinase C by 12-O-tetradecanoylphorbol-13-acetate (phorbol ester) in rat mesangial cells in culture leads to an increase in PGE2 release. Phorbol ester stimulated PGE2 release was significantly inhibited by cyclosporin A. These results would suggest that intracellular site of action of cyclosporin A, in producing alterations in intracellular function and toxicity, may be at the level of protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2712833     DOI: 10.1016/0006-291x(89)91671-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Cyclosporin A stimulates apical Na+/H+ exchange in LLC-PK1/PKE20 proximal tubular cells.

Authors:  Thomas Epting; Kathrin Hartmann; Anna Sandqvist; Roland Nitschke; Nader Gordjani
Journal:  Pediatr Nephrol       Date:  2006-05-11       Impact factor: 3.714

2.  Modulation of Multidrug Resistance in Cancer by Immunosuppresive Agents. Preclinical Studies.

Authors:  Adorján Aszalos
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

3.  Cyclosporin A, FK506 and dithranol after tyrosine-specific protein phosphorylation in HaCaT keratinocytes.

Authors:  H M Ockenfels; G Nussbaum; T Schultewolter; P M Burger; M Goos
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

4.  Effect of cyclosporin-A treatment on endotoxin-induced airway hyperreactivity in vivo and in vitro in guinea-pigs.

Authors:  A J Van Oosterhout; F M Woutersen-Van Nijnanten; F P Nijkamp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

5.  Effects of tiflucarbine as a dual protein kinase C/calmodulin antagonist on proliferation of human keratinocytes and release of reactive oxygen species from human leukocytes.

Authors:  L Hegemann; R Fruchtmann; B Bonnekoh; B H Schmidt; J Traber; G Mahrle; R Müller-Peddinghaus; L A van Rooijen
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

Review 6.  Pharmacologic circumvention of multidrug resistance.

Authors:  J M Ford; W N Hait
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

7.  Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells.

Authors:  H J Broxterman; H M Pinedo; G J Schuurhuis; J Lankelma
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

8.  The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance.

Authors:  G J Schuurhuis; H J Broxterman; H M Pinedo; T H van Heijningen; C K van Kalken; J B Vermorken; E C Spoelstra; J Lankelma
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.